Meeting
2013 ASCO Annual Meeting
Effect of primary tumor size in patients with metastatic non-small cell lung cancer (NSCLC).
Authors
Bing Xia
Yale School of Medicine, New Haven, CT
Bing Xia , Feng Gao , Ramaswamy Govindan , Daniel Morgensztern
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 8041)
DOI
10.1200/jco.2013.31.15_suppl.8041
Abstract #
8041
Poster Bd #
32E
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Association of low RKIP expression with poor prognosis in non-small cell lung cancer.
First Author: Lingbin Meng
Poster
2020 ASCO Virtual Scientific Program
Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy.
First Author: Lova Sun
Poster
2017 ASCO Annual Meeting
Impact of prior radiation on survival in metastatic lung cancer ECOG-ACRIN trials.
First Author: Saad A. Khan
First Author: Sara Moore